Home
Conditions
Neoplasms, Nerve Tissue

Clinical trial condition

Neoplasms, Nerve Tissue

Explore clinical trials studying Neoplasms, Nerve Tissue. Study availability and eligibility vary by location and protocol.

6,284 public trials 1,281 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Nerve Tissue trial results

Recruiting

Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma

NCT06910306

Conditions: Astrocytoma, Glioblastoma, Glioma, +9 more
Locations: Honor Health Scottsdale, Arizona, United States

NYU Langone Health New York, United States

Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Recruiting

Tebentafusp-tebn With LDT in Metastatic UM

NCT06626516

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +15 more
Locations: Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Recruiting

Connectome-guided Onco-functional Resection With Tractography-Extended Neuronavigation in Brain Tumor Surgery

NCT07717827

Conditions: Brain (Nervous System) Cancers, Brain Connectivity, Brain Diseases, +18 more
Locations: Unit of Neurosurgery - A.R.N.A.S. Civico Di Cristina Benfratelli - 90127, Palermo - Italy Palermo, PA, Italy

View Trial Details

Recruiting

Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors

NCT05629546

Conditions: Advanced Melanoma, Melanoma, Metastatic Melanoma, +11 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Recruiting

NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma

NCT07211737

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +16 more
Locations: Texas Children's Hospital Houston, Texas, United States

View Trial Details

Recruiting

A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma

NCT06672575

Conditions: Astrocytoma, Glioblastoma, Glioma, +7 more
Locations: The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States

The University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Embolization for Meningioma

NCT05416567

Conditions: Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +10 more
Locations: St Olavs Hospital Trondheim, Norway

View Trial Details

Recruiting

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

NCT06814496

Conditions: Adenocarcinoma, Astrocytoma, Bladder Cancer, +74 more
Locations: Arizona Cancer Center at UMC North/University Medical Center Tucson, Arizona, United States

University of Washington Fred Hutchinson Cancer Center Seattle, Washington, United States

View Trial Details

Recruiting

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

NCT04924075

Conditions: Abnormalities, Multiple, Adenoma, Adenoma, Islet Cell, +31 more
Locations: Cedars-Sinai Medical Center ( Site 0110) Los Angeles, California, United States

Northwestern University - Robert H. Lurie Comprehensive Cancer Center ( Site 0130) Chicago, Illinois, United States

Northwestern Medicine Cancer Center - Warrenville ( Site 0134) Warrenville, Illinois, United States

University of Iowa ( Site 0104) Iowa City, Iowa, United States

View all 84 locations

View Trial Details

Recruiting

Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma

NCT06995872

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Neoplasms, Nerve Tissue

Neoplasms, Nerve Tissue trial results

Related conditions